| Bioactivity | LRRK2-IN-16 (compound 25) is a LRRK2 kinase inhibitor with an IC50 < 5 μM. LRRK2-IN-16 can be utilized in neurodegenerative disorders and autoimmune disorders research[1]. |
| CAS | 852375-30-5 |
| Formula | C18H19N5OS |
| Molar Mass | 353.44 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. Robert AG, et al. Triazolopyridazine compounds, use as inhibitors of the kinase lrrk2, and methods for preparation thereof. WO2013166276A1. 2013-11-07 |
LRRK2-IN-16
CAS: 852375-30-5 F: C18H19N5OS W: 353.44
LRRK2-IN-16 (compound 25) is a LRRK2 kinase inhibitor with an IC50 < 5 μM. LRRK2-IN-16 can be utilized in neurodegenera
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.